Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Understanding Ghana's FDA and pharmacovigilance regulations

Pharmacovigilance Education for the oncology community in Africa

1 Apr - 28 May 2025

Published: 16 Jun 2025

Views: 208

Rating:

Save

Ms. Priscilla Aduse-Poku

Ghana's FDA regulates medical products to ensure safety and effectiveness, requiring local representatives for market authorization.

The Public Health Act 851 of 2012 establishes a legal framework for safety monitoring. Local representatives monitor product safety and report adverse events, while the FDA analyses drug reactions.

Currently, there are no specific pharmacovigilance requirements for anti-cancer medicines, and Market Authorization Holders must appoint qualified persons for pharmacovigilance.

Related Videos

Enhancing medicine safety monitoring in Zambia

Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia

Enhancing medicine safety monitoring in Zambia ( Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia )

The evolution of pharmacovigilance: Lessons from thalidomide

Sihle Mchunu - Novartis, Johannesburg, South Africa

The evolution of pharmacovigilance: Lessons from thalidomide ( Sihle Mchunu - Novartis, Johannesburg, South Africa )

Understanding pharmacovigilance in Namibia

Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia

Understanding pharmacovigilance in Namibia ( Chelsea Moller - Namibia Medicines Regulatory Council (NMRC), Windhoek, Namibia )

Key Insights from ASCO 2024

Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology...

Key Insights from ASCO 2024 ( Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology (ASCO), USA )

Cancer in emergencies: What can we do better to protect the most vulnerable?

Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara...

Cancer in emergencies: What can we do better to protect the most vulnerable? ( Prof Tezer Kutluk - Turkish Association for Cancer Research and Control, Ankara, Turkey )

Tele-mentoring: Impact of project ECHO

Dr Sanjeev Arora - Project ECHO, Albuquerque, USA

Tele-mentoring: Impact of project ECHO ( Dr Sanjeev Arora - Project ECHO, Albuquerque, USA )

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale...

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )

ASCO's strategic plan for cancer care in LMICs

Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA

ASCO's strategic plan for cancer care in LMICs ( Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA )

McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in...

Ms Soumita Ghose - Tata Medical Center, Kolkata, India

McVie-Veronesi awards: 1st Prize - Insights into journeys of cancer patients in India - Access, affordability and barriers ( Ms Soumita Ghose - Tata Medical Center, Kolkata, India )

More from ecancer

An Error Occurred: Internal Server Error

Oops! An Error Occurred

The server returned a "500 Internal Server Error".

Something is broken. Please let us know what you were doing when this error occurred. We will fix it as soon as possible. Sorry for any inconvenience caused.